Complement factors C3a and C5a are increased in bronchoalveolar lavage fluid after segmental allergen provocation in subjects with asthma

被引:149
作者
Krug, N
Tschernig, T
Erpenbeck, VJ
Hohlfeld, JM
Köhl, J
机构
[1] Fraunhofer Inst Toxicol & Aerosol Res, Dept Immunol Allergol & Clin Inhalat, D-30623 Hannover, Germany
[2] Hannover Med Sch, Dept Resp Med, D-3000 Hannover, Germany
[3] Hannover Med Sch, Dept Funct & Appl Anat, D-3000 Hannover, Germany
[4] Hannover Med Sch, Dept Microbiol, D-3000 Hannover, Germany
关键词
asthma; complement; C3a; C5a;
D O I
10.1164/ajrccm.164.10.2010096
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Allergic asthma Is thought to be the result of an inappropriate specific immune response against common environmental antigens. However, studies of animal asthma models have also linked the innate immune system, in particular complement factors C3a and C5, to murine airway hyperresponsiveness. Because the possible role of these anaphylatoxins in patients with asthma is not understood, we tested the hypothesis that C3a and C5a will increase in the bronchoalveolar lavage (BAL) fluid of patients with asthma after segmental allergen provocation, In a group of 15 subjects with mild asthma we found a significant upregulation of C3a and C5a 24 h after allergen challenge compared with baseline values (p < 0.01). In a control group of healthy volunteers the concentrations remained basically unchanged. Furthermore, we found a strong correlation between both anaphylatoxins and the number of eosinophils (p < 0.01) and, to a lesser degree, with the number of neutrophils (p < 0.05) in BAL fluid. These data suggest a contribution of anaphylatoxins C3a and C5a to the pathogenesis in asthma. However, the pathogenic role of these substances in relation to asthma remains to be elucidated, for example, by using anaphylatoxin receptor blockers as a possible new therapeutic principle.
引用
收藏
页码:1841 / 1843
页数:3
相关论文
共 16 条
  • [1] Identification of a selective nonpeptide antagonist of the anaphylatoxin C3a receptor that demonstrates antiinflammatory activity in animal models
    Ames, RS
    Lee, D
    Foley, JJ
    Jurewicz, AJ
    Tornetta, MA
    Bautsch, W
    Settmacher, B
    Klos, A
    Erhard, KF
    Cousins, RD
    Sulpizio, AC
    Hieble, JP
    McCafferty, G
    Ward, KW
    Adams, JL
    Bondinell, WE
    Underwood, DC
    Osborn, RR
    Badger, AM
    Sarau, HM
    [J]. JOURNAL OF IMMUNOLOGY, 2001, 166 (10) : 6341 - 6348
  • [2] Cutting edge:: Guinea pigs with a natural C3a-receptor defect exhibit decreased bronchoconstriction in allergic airway disease:: Evidence for an involvement of the C3a anaphylatoxin in the pathogenesis of asthma
    Bautsch, W
    Hoymann, HG
    Zhang, QW
    Meier-Wiedenbach, I
    Raschke, U
    Ames, RS
    Sohns, B
    Flemme, N
    zu Vilsendorf, AM
    Grove, M
    Klos, A
    Köhl, J
    [J]. JOURNAL OF IMMUNOLOGY, 2000, 165 (10) : 5401 - 5405
  • [3] Selective suppression of IL-12 production by chemoattractants
    Braun, MC
    Lahey, E
    Kelsall, BL
    [J]. JOURNAL OF IMMUNOLOGY, 2000, 164 (06) : 3009 - 3017
  • [4] Expression of the complement anaphylatoxin C3a and C5a receptors on bronchial epithelial and smooth muscle cells in models of sepsis and asthma
    Drouin, SM
    Kildsgaard, J
    Haviland, J
    Zabner, J
    Jia, HP
    McCray, PB
    Tack, BF
    Wetsel, RA
    [J]. JOURNAL OF IMMUNOLOGY, 2001, 166 (03) : 2025 - 2032
  • [5] RAPID QUANTIFICATION OF C3A AND C5A USING A COMBINATION OF CHROMATOGRAPHIC AND IMMUNOASSAY PROCEDURES
    HARTMANN, H
    LUBBERS, B
    CASARETTO, M
    BAUTSCH, W
    KLOS, A
    KOHL, J
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 1993, 166 (01) : 35 - 44
  • [6] Heller T, 1999, J IMMUNOL, V163, P985
  • [7] Complementing asthma
    Henson, P
    [J]. NATURE IMMUNOLOGY, 2000, 1 (03) : 190 - 192
  • [8] Dysfunction of pulmonary surfactant in asthmatics after segmental allergen challenge
    Hohlfeld, JM
    Ahlf, K
    Enhorning, G
    Balke, K
    Erpenbeck, VJ
    Petschallies, J
    Hoymann, HG
    Fabel, H
    Krug, N
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (06) : 1803 - 1809
  • [9] A role for the C3a anaphylatoxin receptor in the effector phase of asthma
    Humbles, AA
    Lu, B
    Nilsson, CA
    Lilly, C
    Israel, E
    Fujiwara, Y
    Gerard, NP
    Gerard, C
    [J]. NATURE, 2000, 406 (6799) : 998 - 1001
  • [10] Identification of complement factor 5 as a susceptibility locus for experimental allergic asthma
    Karp, CL
    Grupe, A
    Schadt, E
    Ewart, SL
    Keane-Moore, M
    Cuomo, PJ
    Köhl, J
    Wahl, L
    Kuperman, D
    Germer, S
    Aud, D
    Peltz, G
    Wills-Karp, M
    [J]. NATURE IMMUNOLOGY, 2000, 1 (03) : 221 - 226